Kintor Pharma says alopecia primary endpoint met
Kintor Pharma has announced results of a phase II clinical trial for its potential topical drug to treat adult female androgeneticalopecia.
Source: labiotech.eu
Savin Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Savin Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Savin Scale Today - Breaking & Trending Today
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met
DJ Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor
Source: finanznachrichten.de
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met
/PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...
Source: prnewswire.com